Novel angiogenesis inhibitors
A Standard patent application filed on 14 January 2000 credited to Fraley, Mark E.
;
Tebben, Andrew J.
;
Hungate, Randall W.
Details
Application number :
28512
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Novel angiogenesis inhibitors
Inventor :
Fraley, Mark E.
;
Tebben, Andrew J.
;
Hungate, Randall W.
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
14 January 2000
Associated companies :
Applicant name :
Merck & Co., Inc.
Applicant address :
126 East Lincoln Avenue Rahway NJ 07065 United States Of America